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Abstract
Background: MicroRNAs (miRNAs) are a class of non-protein-coding genes that play a crucial regulatory role in
mammalian development and disease. Whereas a large number of miRNAs have been annotated at the structural
level during the latest years, functional annotation is sparse. Actinobacillus pleuropneumoniae (APP) causes serious
lung infections in pigs. Severe damage to the lungs, in many cases deadly, is caused by toxins released by the
bacterium and to some degree by host mediated tissue damage. However, understanding of the role of microRNAs
in the course of this infectious disease in porcine is still very limited.
Results: In this study, the RNA extracted from visually unaffected and necrotic tissue from pigs infected with
Actinobacillus pleuropneumoniae was subjected to small RNA deep sequencing. We identified 169 conserved and
11 candidate novel microRNAs in the pig. Of these, 17 were significantly up-regulated in the necrotic sample and
12 were down-regulated. The expression analysis of a number of candidates revealed microRNAs of potential
importance in the innate immune response. MiR-155, a known key player in inflammation, was found expressed in
both samples. Moreover, miR-664-5p, miR-451 and miR-15a appear as very promising candidates for microRNAs
involved in response to pathogen infection.
Conclusions: This is the first study revealing significant differences in composition and expression profiles of
miRNAs in lungs infected with a bacterial pathogen. Our results extend annotation of microRNA in pig and provide
insight into the role of a number of microRNAs in regulation of bacteria induced immune and inflammatory
response in porcine lung.
Keywords: MicroRNA, RNAseq, High throughput sequencing, RT-qPCR, Actinobacillus pleuropneumoniae, Pig,
Pleuropneumonia
Background
MicroRNAs (miRNAs) are approximately 22 nucleotide
(nt) long molecules, constituting a highly abundant class
of non-coding RNAs (ncRNAs) encoded in the genome
of all eukaryotes [1]. Over the last few years thousands
of microRNAs have been discovered in different organ-
isms and the conservation of most of the microRNAs
has been confirmed across species [2], [3]. This novel
class of ncRNAs provides a new, exciting view on gene
regulation mechanism at the post transcriptional level
by down-regulating their target mRNAs [4]. Finely tuned
gene expression is crucial to physiological processes like
embryonic development, cellular differentiation, cellular
growth control, homeostasis and response to external
stress factors such as pathogens. With a growing num-
ber of studies, it is becoming more apparent that micro-
RNAs play a pivotal role in various physiological and
developmental processes [5]. Some microRNAs are dif-
ferentially expressed in a developmental-stage–specific,
tissue-specific or pathological-stage-specific manner which
is consistent with their gene regulatory function, while
others seem to be present constitutively, suggesting their
role in homeostasis mechanisms [6]. An increasing num-
ber of studies report the crucial role of microRNAs in
human disorders and disease progression. De-regulation
of many microRNA species has been associated with
pathological states including cancer, neurodegenerative
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disorders, diabetes, bacterial infections and immuno-
logical response to the latter [5].
In protection against intruding pathogens, an organ-
specific as well as a systemic immunological host re-
sponse is activated. This response is activated by the
presence of so called pathogen-associated molecular pat-
terns (PAMPs) that are sensed by Pattern Recognition
Receptors (PRRs), for instance the Toll-like receptor
(TLR) [7]. Stimulation of PRRs leads to activation of the
innate and adaptive immune response, elimination of
the detected invading pathogen and development of a
long lasting immunity against it. This complex and
highly organized line of defense requires precisely
balanced and well managed regulatory events for its
proper function. Imbalanced inflammatory response may
lead to septic shock-like condition that can cause death
of the host due to multiple organ failure [8]. The expres-
sion of microRNAs involved in host response to patho-
gens is well established in viral infections [9], [10].
MicroRNAs like miR-29a and miR-32 have been found
to repress the expression of viral mRNAs by possible
recognition and targeting of viral nucleic acids with
miR-29 specifically targeting HIV-1 3’UTR region [11],
[12]. In contrast, replication of HCV (hepatitis C virus)
is dependent on the activity of miR-122 [13]. Neverthe-
less, the role of mammalian microRNAs in bacterial
infections is still in its infancy. There is evidence indicat-
ing strong involvement of microRNAs in immune re-
sponse and inflammation after bacterial infection [14],
[15]. TLRs recognizing PAMPs have been found to regu-
late several microRNAs. For example, miR-146a/b and
miR-155 have been induced by TLR4-mediated sensing
of bacterial lipopolysaccharide (LPS) [16], [17]. It has
been shown that the nuclear factor kappa-light-chain-
enhancer of activated B cells (NF-κB), a central transcrip-
tion factor for a wide range of innate immune factors
including several cytokines, interacts with the promoter
region of miR-146a [16]. LPS stimulation results in up
regulation of miR-155 expression. This microRNA is also
believed to be under direct regulation of NF-κB and sim-
ultaneously regulating it [18]. Moreover, miR-155 has
been shown to be induced by the bacterium Helicobacter
pylori, a known pathogen of the human stomach [19]
and has been proven to act as a global immune regulator
in endotoxin-tolerant macrophages, proving that micro-
RNA expression depends strongly on the status of infected
cells [20].
Actinobacillus pleuropneumoniae (APP), serotype 5b is
a bacterial pathogen infecting the porcine respiratory
track, causing pleuropneumonia [21]. The disease causes
severe economic losses to the pig industry. Very import-
ant virulence-associated factors of APP are the three dif-
ferent exotoxins belonging to the RTX family (Repeat in
the structural ToXin, a family of exotoxins produced by
gram-negative bacteria). The toxins cause serious dam-
age to the lungs and interact with host immunity. The
bacterium is represented by at least 12 different sero-
types. Serotypes 1, 5, 9, 11, and 12 are usually highly
virulent [22]. The complete picture of APP pathogenesis
and host response to the infection has not yet been un-
raveled. There is a considerable lack of knowledge about
the role that microRNAs play in APP infection. To our
knowledge this is the first study on microRNA expres-
sion profiles in porcine lung tissue infected with Actino-
bacillus pleuropneumoniae. However, the expression
profiles of protein coding genes in APP infection have
been studied previously by [23].
The pig (Sus scrofa) has a high economic value for
meat production worldwide and is an important animal
model for biomedical research. The availability of a
nearly completed assembly of the porcine genome allows
annotation of various classes of ncRNAs and further
provides possibilities for assigning function of those key
molecules (microRNA) to the gene regulatory network.
Yet, since the early studies of miRNAs in the pig gen-
ome [24,25], the number of porcine microRNAs depos-
ited in miRBase [26-29] is considerably smaller than the
number of miRNAs in human or mouse. The newest
version of miRBase 18.0 includes 1727 microRNA en-
tries in Homo Sapiens, 741 in Mus musculus and only
228 in Sus scrofa. More studies on porcine microRNAs
are required for expansion of the repertoire of these
small regulatory elements involved in development,
growth and pathological conditions. The present study
utilizes high throughput sequencing technology as well
as bioinformatic tools to obtain expression profiles of
microRNAs in porcine lung samples representing nec-
rotic and visually unaffected areas, 14–18 h after experi-
mental infection with Actinobacillus pleuropneumoniae.
The above mentioned approaches to small RNA expres-
sion profiling, discovery and target predictions are
reviewed in [30]. We detected a significant de-regulation
of a number of host microRNAs during bacterial infec-
tion. A large number of those de-regulated microRNAs
have putative target sites in genes involved in acute
phase response; LPS induced innate immunity response
to pathogens and apoptosis. The majority of the micro-
RNA candidates selected for validation in the present
study are found to target multiple (more than 10 dif-
ferent) protein coding genes. Moreover, several novel
microRNAs have been discovered including one micro-
RNA showing particularly high expression (i.e., included
in top 20 most expressed microRNAs) in porcine lung.
Interestingly, this putative novel microRNA appears to
be specific for pig and closely related species as cow and
dolphin. This is the first study elucidating the expression
of microRNAs and their regulatory networks in pigs
exposed to bacterial pathogen infection. Taken together,
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our data suggest that bacterial infection causes signifi-
cant changes in the expression profiles of microRNAs
within the infected lung, thus affecting the regulation of
genes involved in the immunological response to inflam-
mation and apoptosis.
Results
Overview of high throughput sequencing, alignment and
clustering
To investigate the composition and dynamic changes of
ncRNA (miRNA in particular) expression in lung tissue
from pigs infected with APP, we constructed two small
RNA libraries that were sequenced using Illumina GAIIx
high throughput sequencing technology. A pool of eight
samples from necrotic areas was used to create the nec-
rotic library and the unaffected library was constructed
out of ten pooled samples from visually unaffected areas.
Illumina GAIIx sequencing generated 15,034,867 raw
reads (un-normalized reads) in the necrotic sample and
12,544,524 raw reads in the visually unaffected sample,
after filtering of low quality reads (Chastity > 0.6). For
the necrotic sample, sub sequential adapter removal and
quality filtering, resulted in a total of 11,997,185 18–34
nt long reads. Only high quality reads where accepted
for alignment by Novoalign [31]. In the same sample, a
total of 10,506,718 raw reads aligned to the pig genome
[32] version 9 and 7,862,371 of these aligned uniquely.
For the visually unaffected sample the corresponding
numbers of raw reads were 9,452,155, 7,305,262 and
5,634,264, respectively. In this study, we only used reads
that aligned uniquely (does not apply to miRDeep2 pipe-
line). The typical size range corresponding to mature
microRNA sequences is between 19 and 25 nt. Among
millions of uniquely aligned, high quality reads, 74% and
25% in the visually unaffected and necrotic library re-
spectively, belong to this size range. The visually un-
affected sample follows the typical read distribution for
small RNA sequencing with a majority of raw reads
belonging to the mature miRNA range of 19–25 nt
(Figure 1). Both libraries were rather complex in their
composition, including various classes of ncRNAs as
well as a large number of degradation products of dif-
ferent length originating mostly from coding but also
non coding transcripts as well as repetitive elements.
The degradation products were particularly distinct in
the necrotic sample, which explains the difference in
the read size distribution between the two libraries
(Figure 1).
Using reads that aligned uniquely to the pig genome
version 9, we found 361,430 read clusters shared be-
tween the libraries (Table 1). The number of clusters
depends heavily on the cutoff based on the number of
reads in the cluster. With cutoffs of 5 and 10, we found
26,465 and 10,331 read clusters, respectively. To reduce
the number of false positives on one hand, while pre-
serving the opportunity to discover low expressed miR-
NAs on the other, we chose to use the 26,465 clusters
with raw read count of at least 5 in one of the two li-
braries for further analysis.
Table 1 shows that in both the necrotic and the visu-
ally unaffected samples the number of raw reads forming
clusters with more than five reads comprises over 90%
(95.7% and 97.6%, respectively) of all the reads.
Figure 1 The distribution of raw reads versus read lengths in both libraries. X axis shows the insert length while Y axis represents raw
reads. Necrotic area sample is marked in blue whereas visually unaffected area sample is marked in red.
Table 1 The result of the alignment, clustering and
annotation of the reads
Classes of reads Raw reads Read clusters
Necrotic Unaffected
Raw reads 15034867 12544524
Filtered reads 11997185 9452155
Aligned reads 10506718 7305262
Uniquely aligned reads 7862371 5634264 394631
Clusters with >= 5 reads 7412475 5568204 26465
Clustering of raw reads is obtained after the alignment to the reference
genome.
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Annotation
NcRNA detection by homology and class-specific tools
We annotated the main classes of ncRNAs using an in
house ncRNA pipeline (see the Methods section for
details) and we used the protein annotation from
Ensembl version 56 [33] to annotate the messenger
RNAs. Finally, 9,776 out of 24,808 merged read clusters
were successfully annotated (Table 2). Various ncRNA
classes including miRNA, snRNA, snoRNA, tRNA,
scaRNA (169, 40, 169, 73, 11 clusters, respectively) were
found. There are great differences in the amount of
rRNA/mRNA/microRNA raw reads when comparing
the two libraries as shown in Figure 2. This result can be
explained by degradation occurring more intensively in
the necrotic sample in such an advanced stage of infec-
tion. A total of 5,707,949 uniquely mapped raw reads
corresponded to rRNA genes in the necrotic sample,
while the number of reads annotated as rRNA in the
sample from visually unaffected areas was 296,778 reads,
or 19 times less. The situation is reversed when looking
at the number of reads for microRNAs. The necrotic
sample is represented by 783,324 raw reads annotated as
microRNA whereas the visually unaffected is repre-
sented by 4,652,256 raw reads, which is almost 6 times
more than in the necrotic sample (Table 2). This dra-
matic decrease in miRNA can be understood as follows:
As the concentration of rRNAs increases, so does the
rRNA sampling probability and the sampling probability
of the miRNA must conversely drop.
Detection of miRNAs by homology
The known miRNAs were identified by BLAST [34]
against miRBase or by infernal 1.0 [35] with the models
from Rfam9 [36]. We detected 169 miRNAs using high
confidence BLAST (95% identity and 95% length)
against the hairpins from miRBase version 15. Of the
total of 169 miRNAs with annotated hairpins, 142 were
ssc miRBase hairpins and 27 were annotated hairpins
from other organisms. In addition, five miRNAs were not
recognized by high confident BLAST, but were matched
by Rfam/infernal as members of miRNA families.
Detection of novel miRNAs
A distinct pre-miRNA hairpin structure is a primary cri-
terion for microRNA annotation. The hairpin structure
and characteristic read patterns of miRNAs makes them
much easier to detect than other novel ncRNAs in gen-
eral [37,38]. In the present study novel miRNAs were
predicted with miRDeep2 [39]. The Bowtie [40] mapping
performed by the miRDeep2 pipeline reports reads with
up to five matches to the genome.
We found 303 miRNAs annotated by miRDeep2 where
221 were from known miRNAs and eight were from
other types of ncRNAs. Overlapping the miRDeep2
results with the Novoalign read clusters of at least five
uniquely mapped raw reads, we confirm 201 of the 303
miRDeep2 detected miRNAs. Among the 201 clusters
Table 2 Annotation summary
Classes of reads Raw reads Read clusters
Necrotic Unaffected
Merged clusters with >=5 reads 7412475 5568204 24,808
Un-annotated 317709 135674 15032
Annotated 7094766 5432530 9776
rRNA 5707949 296778 25
miRNA(mirBase hairpin) 783324 4652256 169
Protein 204431 12494 9260
snRNA 178170 2757 40
snoRNA 172592 416729 169
yRNA 29110 18711 5
Conflicts 9511 22853 22
tRNA 6327 6397 73
scaRNA 1801 854 11
Others 1551 2701 3
The read clusters with at least five reads are subjected to annotation. The
ncRNAs are annotated with our in house ncRNA pipeline; the mRNAs are
annotated according to the Ensembl protein annotation of the pig. In case of
overlapping annotation the read clusters were merged. The classification of
the ncRNAs is in accordance with Rfam. Small Cajal body-specific RNA
(scaRNA).
Figure 2 The distribution of raw reads between various RNA classes in A) visually unaffected sample and B) necrotic sample.
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Table 3 The novel miRNAs of the miRDeep2 pipeline
Novel miRNA
(miRBase name)
Mature sequence Star sequence Coordinates/strand Raw reads
in Necrotic
Raw reads
in Unaffected
Novoalign
Mature Star Mature Star Necrotic VU
miR-d1 miR-7142 uuuguuggcuccucugaaguga acucuccgaggggccuucaaggg chr2:6684269–6684379:- 30 1 49 0 15 8
miR-d2 miR-7138 gaggacuggccuugcagggugc ucccagcaaguguccauccaucu chr2:69969933–69970043:+ 21 9 1 4
miR-d3 miR-7137 agcuggucugggaguucccggg cgggggaacucccagaccagc chr3:9289209–9289319:+ 25 8 5 5
miR-d4 miR-7135 aucugucugugucucugagcag ucucugagacacugacugugg chr3-25819302-25819413:+ 5 3 72 8 4 14
miR-d5 miR-7134 augcggaaccugcggauacgg auguccgcggguucccuaucc chr5:4391270–4391380:- 8,622 32 20,234 161 5413 3690
miR-d6 miR-7139 uagggcacaggaugggaugagg ccauuccuucgucugugcacuag chr5:97203430–97203540:+ 12 4 2 3
miR-d7} miR-2320 uggcacaggguccagcugucgg cgaugauggucccuguguuugg chr6:43886614–43886725:- 28 10 224 37 19 32
miR-d8 miR-7136 ucugguccagacacuguggagc ucucaguguuugaaccagaagc chr7:8508420–8508531:- 23 14 3 7
miR-d9 miR-7143 ucugcacuugaagcugagacuga aagcucagcucugaagugcagagg chr9:27778763–27778873:+ 11 0 1 2
miR-d10 miR-7144 acuuucccgggauuuggagcgc gcuccuugucccgagaccgcga chr11:74962849–74962958:+ 10 0 11 2
miR-d11 miR-7141 gacgguuuggacguuaagaac ucuuaacguccaaaccguucc chr15:129475498–129475608:+ 21 0 1 4
miR-d12 miR-7140 aaugaugccccuuagaguugag caacucaagggggcaucauuca chr17:37143888–37143999:+ 30 1 11 2 14 2
Predictions are confirmed by the unique mappings from Novoalign and either conserved structure according to RNAz or by having reads in both mature and star. 12 miRNAs are novel according to mirBase. Read
counts in this table are based on raw reads and refer to the Bowtie mapping used by miRDeep2. VU stands for visually unaffected. One miRNA (miR-d7) marked with a } is mir-2320, found in mirBase17 so cannot
be any longer considered novel.
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found by both miRDeep2 and the clustering of the reads
aligned with Novoalign, 4 predictions were also matched
to non-miRNA infernal families, 160 were aligned to
known miRNAs, and 37 were predicted to be new, un-
annotated miRNAs.
These 37 novel predictions were further evaluated by
requiring at least five reads detected by miRDeep2, and
either both mature and star sequences to be present, or
alternatively structure conservation of the site by RNAz
pre-release version 2 [41]. After curation, 11 predicted
novel miRNAs, which are listed in Table 3, remained. In
miRBase 18.0 miR-d7 is annotated as ssc-mir-2320
which was not known in the miRBase version 15 used
for the annotation pipeline (Figures showing read profile
for each of the novel microRNAs are in Additional files
1 and 2). The Bowtie mapping of the reads revealed a
number of known miRNAs not present in the Novoalign
mapping of which 24 were expected to be detected only
once in the reference genome, but were found twice in
close proximity, indicating errors in the assembly
(Additional file 3).
Profiles of expression during APP infection
Characterization of the libraries composition
The ncRNAs of the necrotic tissue are dominated by the
degraded rRNAs. Other long ncRNAs also show high raw
read counts compared to the unaffected tissue. It may, how-
ever, be noted that the fraction of tRNAs are comparable in
the two samples. The summed raw reads of the microRNAs
in particular as well as snoRNAs are much lower in the
necrotic sample compared to the visually unaffected one.
We annotated 9260 clusters as being parts of protein
coding genes (exons). The raw reads for these clusters
are quite different between the samples, 204,431 and
12,494 reads in necrotic and visually unaffected respect-
ively, which underlines the higher degree of degradation
of mRNAs in the necrotic tissue which poses challenges
in the interpretation of the microRNA expression levels
(Table 2).
Highly abundant microRNAs
High throughput Illumina GAIIx sequencing revealed a
number of highly expressed microRNAs. We present the
Table 4 The top 20 miRNAs in either sample, ordered by number of necrotic reads
Annotation Annotation coordinates Normalized read counts log2(FC) p-value
Necrotic Unaffected
mir-143 chr2:136030751–136030831:+ 697353.81 461481.09 −0.60 3.64E-001
mir-21 chr12:34201564–34201656:+ 57776.26 122252.79 1.08 1.02E-001
mir-451 chr12:42820765–42820830:- 49029.44 3944.06 −3.64 5.16E-007
mir-30a chr1:53848997–53849104:- 46416.19 109713.26 1.24 6.12E-002
mir-148a chr18:45214547–45214615:- 25801.77 26340.33 0.03 9.64E-001
let-7 g chr13:28999418–28999498:+ 23644.76 10926.89 −1.11 9.22E-002
mir-126 chr1:294113068–294113141:+ 15131.46 54694.16 1.85 5.98E-003
mir-30e chr6:121824300–121824380:- 12711.24 15622.78 0.30 6.49E-001
mir-142 chr12:32630402–32630482:- 11700.22 2961.25 −1.98 3.43E-03
miR-d5 chr5:4391269–4391380:- 10960.52 3887.77 −1.50 2.51E-02
miR-223 chrX:51247504–51247526:- 10712.16 367.80 −4.86 2.38E-10
mir-144 chr12:42820909–42820993:- 8968.19 1426.54 −2.65 1.34E-04
mir-10a chr12:22389423–22389503:- 8433.66 26108.75 1.63 1.50E-02
mir-30d chr4:5729458–5729537:+ 8170.45 10106.35 0.31 6.39E-01
mir-23a chr2:56861158–56861228:- 5968.90 3586.67 −0.73 2.64E-01
mir-27b chr10:26148775–26148855:- 5775.87 10319.10 0.84 2.03E-01
mir-191 chr13:26605640–26605720:- 4910.64 3262.54 −0.59 3.69E-01
mir-146b chr14:118471587–118471686:+ 3848.33 4350.12 0.18 7.87E-01
let-7c chr13:130665020–130665114:+ 3605.36 5812.52 0.69 2.94E-01
mir-146a chr16:60604389–60604467:+ 3486.58 635.24 −2.46 3.68E-04
mir-23b chr10:26149009–26149089:- 2741.48 3640.56 0.41 5.33E-01
mir-1 chr17:64096221–64096329:+ 1986.93 3300.20 0.73 2.66E-01
mir-152 chr12:21743214–21743294:+ 1764.21 3394.96 0.94 1.53E-01
mir-99b chr6:39533215–39533285:+ 1434.86 3234.90 1.17 7.72E-02
The reads shown in the table are normalized to counts per million calculated by the TMM normalized sample size, the log2 of the fold change (positive for down
regulation in the necrotic tissue) and the p-values are determined by the exact-test.
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20 most abundant microRNAs in both samples
(Table 4). Most of the top 20 miRNAs are annotated in
pig in miRBase, with the exception of mir-223, mir-144
and a novel miRNA (miR-d5). Noteworthy, the top
two, most abundant microRNAs, namely miR-143 and
miR-21 are shared between the two libraries. In each
sample, miR-143 has by far, the highest number of
reads constituting 65% and 49% of all normalized
microRNA reads (read counts) in the necrotic and the
visually unaffected sample, respectively.
After normalization of the raw reads accordingly we
found that 17 of the 180 known and novel miRNAs were
significantly up regulated in the necrotic sample with an
e-value cutoff of 0.05. Similarly, 12 miRNAs were signifi-
cantly down regulated (Table 5). Interestingly, the highly
expressed novel miRNA on the negative strand of
chromosome 5 called miR-d5 is present in the top 20
most abundant microRNAs and shows up regulation in
the necrotic sample (Table 4 and Table 5). This novel
microRNA is only found in pig, cow and dolphin. The
complete list of 180 known and novel miRNAs is pro-
vided in Additional file 4.
The top 20 most expressed snoRNAs show a much
larger variation between the two samples. Nine are
common in the top 20 list of most expressed snoRNAs
in the two respective samples (for details see
Table 5 The miRNAs significantly up or down regulated in the necrotic tissue, ordered by the fold change (FC)
Annotation Annotation coordinates Normalized read counts log2(FC) p-value
Necrotic Unaffected
miR-223(Q) chrX:51247504–51247526:- 10,712.16 367.80 −4.86 2.38E-10
miR-d12 chr17:37143883–37144004:+ 28.35 1.80 −3.97 2.65E-05
mir-451(Q) chr12:42820765–42820830:- 49,029.44 3,944.06 −3.64 5.16E-07
mir-582 chr16:36589520–36589618:+ 193.02 25.64 −2.91 6.40E-05
mir-7 chr1:200316408–200316468:- 708.65 111.38 −2.67 1.37E-04
mir-144(Q) chr12:42820909–42820993:- 8,968.19 1,426.54 −2.65 1.34E-04
mir-146a(Q) chr16:60604389–60604467:+ 3,486.58 635.24 −2.46 3.68E-04
mir-15b chr13:78787510–78787608:+ 1,150.04 278.66 −2.05 2.70E-03
mir-19a chr11:60972740–60972822:+ 114.73 28.65 −2.00 5.07E-03
mir-142(Q) chr12:32630402–32630482:- 11,700.22 2,961.25 −1.98 3.43E-03
miR-d1 chr2:6684268–6684379:- 31.05 8.21 −1.92 1.83E-02
mir-132 chr12:45599471–45599572:- 82.34 25.04 −1.72 1.70E-02
mir-222 chrX:40478833–40478913:- 134.98 42.87 −1.65 1.77E-02
mir-221 chrX:40478093–40478163:- 827.44 271.44 −1.61 1.71E-02
miR-d5(Q) chr5:4391269–4391380:- 10,960.52 3,887.77 −1.50 2.51E-02
mir-505 chrX:112590811–112590891:+ 62.09 22.04 −1.49 3.84E-02
mir-128-1 chr15:14550873–14550955:- 107.99 40.47 −1.42 4.40E-02
mir-542 chrX:108481538–108481618:- 715.40 1,961.41 1.46 2.97E-02
mir-10a chr12:22389423–22389503:- 8,433.66 26,108.75 1.63 1.50E-02
mir-30c-2 chr1:53819905–53819985:- 80.99 257.42 1.67 1.63E-02
mir-181a-1 chr10:22839351–22839455:- 37.79 122.60 1.70 1.90E-02
mir-138a chr13:23336889–23336951:+ 82.34 272.45 1.73 1.31E-02
mir-497 chr12:49575593–49575673:+ 51.29 181.10 1.82 1.03E-02
mir-126(Q) chr1:294113068–294113141:+ 15,131.46 54,694.16 1.85 5.98E-03
mir-450b chrX:108480528–108480608:- 66.14 248.61 1.91 6.66E-03
mir-100 chr9:47702720–47702800:- 527.78 2,599.26 2.30 8.24E-04
mir-181b-2 chr1:280335867–280335953:+ 2.70 17.03 2.66 2.02E-02
mir-450a chrX:108480687–108480793:- 0.00 13.62 Inf. 1.14E-03
mir-326 chr9:9132229–9132320:- 0.00 5.01 Inf. 4.00E-02
The reads shown in the table are normalized to counts per million calculated by the TMM normalized sample size, the log2 of the fold change (positive for down
regulation in the necrotic tissue) and the p-values are determined by the exact-test. A p-value cutoff of 0.05 was applied. The miRNAs marked with (Q) were
chosen for RT-qPCR.
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Additional files 5 and 6). The present study however,
was mainly focused on microRNA expression therefore
snoRNAs are not investigated in details.
The high throughput sequencing results were further
subjected to validation of candidate miRNA expression
by RT-qPCR. Most of the miRNA candidates are falling
into highly abundant or up/down regulated microRNAs
in the necrotic sample, however the two miRNAs: miR-
15a and miR-155 were chosen due to their biological
relevance as reported in the literature disregarding their
Figure 3 Profile of reads distribution for read cluster annotated as both miR-664-5p and SNORA36. S1-necrotic, S2-visually unaffected
sample.
Figure 4 RT-qPCR analysis of expression of 13 selected unique miRNAs and one snoRNA. miR-d5 represents a novel unannotated
microRNA. Data presented are normalized to the reference genes, LOG2-transformed relative quantities. The level of expression for control sample
is set to zero.
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rather low read count (Additional file 4). The SNORD15
is the third highest expressed snoRNAs, up-regulated in
the necrotic sample (Additional file 5). The ncRNAs
chosen for RT-qPCR validation were: miR-15a, miR-21,
miR-126, miR-142-5p, miR-143-3p, miR-144*, miR-146a-
5p, miR-148a, miR-155, miR-223, miR-451, miR-664-5p,
miR-d5 and SNORD15. Ten of the candidates were highly
expressed in both samples (Table 4) of which seven were
found differentially expressed by RNAseq (Table 5). miR-
664-5p is an interesting case of a so called snoR-like
microRNA [42]. The annotation procedure assigns both
miR-664-5p and SNORD36 to the same locus. For this
reason miR-664-5p is neither featured among micro-
RNAs nor among snoRNAs (Figure 3).
qPCR validation of candidate microRNA expression
High throughput data demand validation of particular
candidates by a technique with higher specificity and
sensitivity like RT-qPCR. In this study, SYBR Green
RT-qPCR was used to verify the expression of 13 select
microRNAs and one snoRNA. Within 13 microRNAs,
12 are annotated in miRBase and one is a novel
microRNA discovered in the present study. Additionally,
miR-152 and miR-191 were used as RT-qPCR reference
genes.
In addition to RNA isolated from visually unaffected
and necrotic tissues, RNA from the demarcation zone
(between infected and non-infected tissue), and from
nose and trachea originating from the same infection
study were included in the RT-qPCR studies. Moreover,
developmental lung (gestation day 50, gestation day 100
and 3 months old ( adult control) were included in order
to obtain microRNA expression profiles across tissues
present in the respiratory tract as well as across develop-
ing uninfected lung tissue. The data for trachea, nose,
F50, and F100 are not included in the main manuscript
however the diagram including all the tissues is present
in Additional file 7. To simplify the graphical representa-
tion of microRNA expression profiles we have included
results from adult (not infected) control lung, necrotic
area, demarcation zone and visually unaffected area only
(Figure 4). For data representation, expression in the
control sample was set to zero.
The ANOVA performed on LOG2 transformed relative
quantities revealed significant differences in the ncRNA
expression between the analyzed tissues. As mentioned
above, Illumina GAIIx high throughput sequencing was
performed on pools of visually unaffected and necrotic
sample only. RT-qPCR, on the other hand provides
additional, complementing results for the demarcation
zone as well as a control sample group. Taking the nature
of the demarcation zone sample (tissue sampled at the
border of necrotic and visually unaffected tissue, see
Figure 5) we would expect the intermediate microRNA
expression rates. The expression levels of all assayed
microRNAs but one and of the snoRNA in the demarca-
tion zone sample are intermediate in relation to the visu-
ally unaffected and necrotic areas.
We arranged the expression profiles of the genes
selected for RT-qPCR in five groups.
Group 1: microRNAs up-regulated in all or some of
the infected samples compared to control (miR-144*
(miR-144-5p in the newest miRBase 18.0 in human),
miR-223, miR-451, miR-664-5p, miR-d5, SNORD15),
(p-values shown in Additional file 8). All of the above
microRNAs and snoRNA show significant up-regulation
of expression in necrotic vs. visually unaffected sample.
Such level of relative expression (RT-qPCR) is highly
comparable to number of reads (sequencing) for each of
the above six ncRNAs.
Group 2: microRNAs down-regulated in necrotic com-
paring to visually unaffected areas and/or control sample
(miR-126, miR-155). The read counts for miR-126 also
showed significantly lower number of counts for the
necrotic sample in comparison to the unaffected sample.
MiR-126 has the highest expression in control sample,
Figure 5 Sampling areas of the porcine lungs infected with
Actinnobacillus pleuropneumoniae. 1 – Necrotic area, within
pulmonary lesion. 2 – Demarcation zone, border area between
visually unaffected and pulmonary lesions. 3 – Visually unaffected
area, which was sampled either from unaffected lung lobe
(3 to the left) or from site as distant from pulmonary lesion as
possible (3 to the right).
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MiR-155 has a slightly different profile with all the
infected samples having significantly lower expression
than the control sample but at the same time the ex-
pression does not differ significantly between samples
representing various stages of infection (similar read
count number confirms this expression pattern).
Group 3: MicroRNAs down-regulated in control
followed by up-regulation in visually unaffected and
down-regulation again in necrotic sample (miR-142-5p,
miR-143-3p, miR-148a). Despite the decreasing trend,
the expression for miR-142-5p and miR-148a, in the nec-
rotic sample remains significantly higher than in the
control. In contrary, miR-143-3p makes a slight exception
by having the expression in necrotic area down-regulated
significantly compared to the control. Expression profile
of miR-142-5p similarly shows lower read count number
in visually unaffected vs. necrotic sample obtained by
sequencing. Surprisingly the differential expression de-
tected by RT-qPCR does not confirm the lack of sig-
nificant differences for the miR-148a and miR-143
shown by RNAseq data.
Group 4: microRNA highly up-regulated in infected
samples vs. control, showing no differences between the
different sampled areas from infected lung (miR-15a).
Among all unique qPCR candidates, miR-15a repre-
sents an exclusive profile of very low expression in the
control sample, followed by remarkable up-regulation
(p-value =1 E-08) in all 3 samples originating from the
infection study. No significant difference of the miR-15a
expression has been detected between the infected sam-
ples (visually unaffected, demarcation zone, necrotic),
which is also reflected in the RNAseq results.
Group 5: Two microRNAs showed no significant dif-
ference (miR-21) between the investigated tissues or a
slightly significant difference (miR-146a-5p) between
control and visually unaffected area (p-value = 0,48). In
contrary, the RNAseq results show up-regulation of
miR-146a-5p placing it within 20 most regulated micro-
RNAs in necrotic sample. MiR-21 is by far, the most
expressed of all the assayed microRNAs, showing very
high, stable expression in the lung tissue, regardless
the presence/degree or absence of infection. However,
according to read counts miR-21 is placed as the sec-
ond most abundant transcript, right after miR-143. Fur-
thermore, the relative expression of miR-21 detected by
RNAseq points towards up-regulation of this microRNAs
in visually unaffected sample in comparison to the nec-
rotic sample (visually unaffected sample contains more
than 2 times more reads than the necrotic).
Target predictions of microRNAs
Regardless of the limited understanding of microRNA
function, microRNA target predictions point out
mRNAs possibly regulated by individual miRNAs. We
combined (conservative) human data from four of the
prominent target prediction methods sources namely:
Targetscan [43-46], pictar [47,48], miRanda [49,50] and
microT [51]. We only included conserved miRNAs and
conserved targets. The merged data contained 1,365,255
predicted interactions between 18,542 proteins and 789
miRNAs. A total of 272,641 predicted protein/miRNA
targets were in agreement with two or more of the four
methods and these constituted our conservative set. For
further miRNA target investigation, the range of possible
targets of interest was narrowed down to 91 transcripts
coding for proteins based on the available literature re-
garding microRNAs in bacterial infection, immunological
Table 6 Predicted mRNA targets for unique miRNA candidates validated by RT-qPCR
Annotation gene targets
miR-15a ALB, BCLAF1, C1QA, C1QB, CD163**, CYP19A1, CYP26B1**, FKBP1A**, FOXP3, IFNGR1, IL10RA**, IL10RB, IL18R1,
IL6R, IRAK1BP1, MAPK8, NFKB1, PAK2, PDCD4**, SFTPD, SMAD7**, SOCS5**, TAB3**, TNFAIP1**
miR-21 CYP19A1, IL10, IL12A**, IL1B**, IRAK1BP1, PDCD4**, SFTPA1, SMAD7**, SOCS5, TAB2, TAB3**, TNFAIP3, ZNF41
miR-126 IL21R, TOM1**
miR-142-5p BCLAF1, CYP26B1, FKBP1A**, IL21R, IL6ST, MCL1**, SMAD2, TNFAIP3, TNFAIP6
miR-143-3p ALB, FN1, IFNG, IL10RA, IL10RB, IL18R1, IL21R, IL6R, IL6ST, IRAK1BP1, KHSRP, MAPK8, PAK2, POSTN TAB2, TNFAIP1, ZEB2, ZNF41
miR-146a-5p BCLAF1, CCBP2**, CCL5, FN1, FTH1, HLA-A, IL6, IRAK1**, POSTN, SMG1, TAB2, TERF1, TNFAIP3, TNFAIP8, TRAF6**, ZEB2, ZNF41
miR-148a ALB, C8A, CYP26B1, HLA-A, IL6ST, IRAK1, SMAD2**, SMAD7, ZEB2
miR-155 BCLAF1, CCL5, CYP26B1**, FN1, FTH1, IFNG, IL12A, IL13**, IL18R1, IL6ST, ILF3, INPP5D**, IRAK1BP1, PAK2**, PDCD4,
SMAD2**, SOCS5**, TAB2**, TERF1**, TNFAIP6, TNFAIP8, ZEB2
miR-223 BCLAF, C8A, CYP26B1, IL6ST**, IRAK1BP1, KHSRP, SMG1, SOCS5, TAB2**, TNFAIP8, ZEB2, ZNF41
miR-451 CFI, IL6, IL6R, PAK2, TNFSF15, TOM1
miR-664-5p A2M, CYP26B1, IFNG, IL18R1**, IL1A**, IL8, JUN, KHSRP, MAPK8, MCL1, NFKB1, SMG1**, TERF1, TNFAIP1**
miR-d5 No predictions found
Only widely conserved target sites included. ** indicate target predicted by two or more algorithms. Bold and underlined protein coding gene symbol indicate
miRNA:mRNA interaction featured in StarBase which includes CLIP-Seq experimental validation.
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response and cell death [14], [15] as well as the tran-
scriptional profiling performed at different sites of lungs
in pigs during acute bacterial respiratory infection [23],
[52]. Moreover, the set of microRNAs subjected to
mRNA predictions was limited to 12 microRNA candi-
dates validated by RT-qPCR (excluding novel miR-d5
and SNORD15). These 12 microRNAs are all conserved
in human as are the proteins targeted by them and we
therefore assume that the microRNA-protein interaction
is conserved as well.
Overlap of the mRNA and miRNA predictions re-
sulted in 149 predicted interactions for the 91 proteins
with the 12 miRNAs of which 35 interactions (cor-
responding to 26 distinct proteins) are predicted by two
or more methods and are shown in Additional file 9.
The miRNA candidates assayed by RT-qPCR are found
to target multiple mRNAs as shown in Table 6. Two out
of 13 microRNAs (miR-15a, miR-155) included in
Table 6 are predicted to target more than 20 different
mRNAs. The following five miRNAs (miR-21, miR-143-
3p, miR-146a-5p, miR-223, miR-664-5p), target over ten
different protein coding genes. MiR-142-5p, miR-148a
and miR-451 target over five mRNAs, whereas only two
predictions were found for miR-126.
The target predictions for the 11 novel miRNAs were
performed with TargetScan against human 3’ UTRs,
keeping only the widely conserved target sites. For the
novel miRNAs we found a total of 1,926 targets. Only
eight out of 1,926 predicted interactions target mRNA
within the selected 91 proteins and these are: CYP26B1:
miR-d11, ILF3: miR-d10, MCL1: miR-d7, PAK2: miR-d3,
miR-d7, miR-d8, SMAD7: miR-d12. SOCS5: miR-d7.
The highly expressed novel miRNA miR-d5 was found
to target only five transcripts, which is an unusual low
number compared to the others. This characteristic is
shared with miR-d11 and it is likely because both miR-
NAs are linage specific and not found in human (see
Additional file 10) which also explains why their targets
are missing from the set of widely conserved target sites.
All targets without consideration of conservation of the
target sites are given in Additional file 11, however, since
the pig is not part of the TargetScan data set while cow
is, we chose to use the cow 3’ UTRs. Thus, we found no
targets of particular interest mostly due to only partial
sequence conservation of both miR-d5 and miR-
d11between pig and cow.
Discussion
In the present study we have mainly been interested in
investigation of microRNAs involved in the progression
of the APP infection rather than comparing infected
versus healthy individuals. Furthermore, we decided to
use infected and visually uninfected tissue from pigs
infected with the bacterial pathogen Actinobacillus
Pleuropneumoniae in order to minimize the genetic
and phenotypic diversity between samples. We have
used these samples to generate expression profiles of
microRNA by high throughput. Working with infected
tissue, which shows severe signs of advanced necrosis,
is challenging because RNA degradation has to be
taken into account. As expected, the annotation of the
RNAseq data revealed a dominating presence of deg-
radation products in the necrotic sample, regardless of
the fact that all the samples included in the present
study showed RNA quality indexes acceptable for gene
expression studies (RQI > 6.0). The read length distri-
bution in the visually unaffected sample is comparable
to profiles generated in other studies [53], [54] with the
highest number of reads belonging to the 19-25nt micro-
RNA range which suggests the reliability of the library
construction and the sequencing. A meaningful expres-
sion profile can only be generated if the raw reads are
normalized in accordance to the degree of degradation.
To avoid letting rRNA and mRNA degradation products
over-shadow the read counts of the miRNAs among the
reads generated in the necrotic sample, the miRNAs
from both samples were studied separately. Two different
mapping methods have been used in this study: one with
unique reads using Novoalign [31], and one with matches
to maximum five genomic loci using Bowtie. The results
generated by the two methods are in strong agreement
with each other.
The sequencing data provide evidence of microRNA
deregulation during lung infection with the bacterial
pathogen. Both up- and down-regulation of microRNAs
were found when comparing the expression in the nec-
rotic versus visually unaffected tissue of the lung. A sub-
set of the highly expressed and biologically relevant
genes (13 miRNAs and one snoRNA) was subjected to
RT-qPCR. In 10 out of 14 genes, RT-qPCR results sup-
ported the results obtained by deep-sequencing indicat-
ing that the data generated reflects a biologically
meaningful profile. The disagreement featured in the
remaining four microRNAs is most likely pointing to-
wards sequencing bias accompanying RNAseq experi-
ments rather than misevaluation of the expression by a
specific and sensitive RT-qPCR.
The number of annotated microRNAs in domestic pig
in the newest miRBase 18.0 is still much smaller than in
other organisms, featuring 1527 entries for human, 741
for mouse and only 228 for pig. Multiple alignments to
the pig genome and 17 other organisms were performed
based on the assumption that the majority of miRNA
sequences are conserved among species [2], [3]. A total
of 27 of the annotated 168 microRNAs matched hairpins
annotated for other organisms than pig in miRBase and
based on sequence homology they could be annotated in
pig enriching the repertoire of porcine microRNAs by
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27 homologous miRNAs. Furthermore, 11 novel micro-
RNAs were found by search performed with miRDeep2
pipeline [39] [55]. Often, novel microRNAs are not
represented by many read counts. An exception to that
rule is one of the detected miRNAs, annotated at the
negative strand of chromosome 5, called – miR-d5,
which is represented by 5413 and 3690 read counts in
necrotic and visually unaffected sample, respectively.
Moreover, this novel microRNA was found in only two
other organisms: cow and dolphin out of the 17 different
reference genomes tested.
Studies on high throughput sequencing of small RNAs
show that there are in most cases a few distinct micro-
RNAs that constitute the majority of microRNA reads
[56]. Our study also reports highly abundant microRNA
namely miR-143 which is represented by 65% and 49%
of the miRNA reads in the visually unaffected and the
necrotic sample, respectively. RT-qPCR validation of this
microRNA did, not reflect such a high level of expres-
sion. Even more striking is the fact that this particular
microRNA has not previously been described as ex-
tremely abundant in mammalian lung, neither has it
been pointed out as a major regulator of immune re-
sponse [57]. A possible explanation for the high read
count in both libraries could be that during the library
construction an artifact has been introduced in the
RNAseq experiment.
The second most abundant microRNA in both sam-
ples – miR-21 is involved in many biological scenarios
[58-61]. In the present study, miR-21 shows down-
regulation in the necrotic sample in comparison to the
visually unaffected one, however supported by quite low
p-values (Table 4). RT-qPCR performed on miR-21
detected the highest expression level of all the assayed
microRNAs. No differential expression was found be-
tween the samples included in the RT-qPCR experiment,
which could indicate an important role of miR-21 in the
homeostasis of lung.
The 12 microRNA candidates assayed by RT-qPCR
were investigated for target predictions in order to provide
more insight into the biological pathways where the differ-
ent microRNAs could play a role. The conservative pre-
dictions indeed anticipated a number of very promising,
biologically interesting interactions. One of the major fac-
tors involved in detection of pathogens and initiation of
inflammatory response are TLRs. Moreover, a rapid im-
mune response is triggered upon pathogen invasion by
the presence of LPSs – a major component of the gram
negative APP membranes. After binding of LPS to the
TLR4/MD2/CD14 receptor complex, signalling pathways
lead to the activation of nuclear factor κB (NF-κB) that
further regulates a large set of genes critical to cell prolif-
eration, inflammation and innate immunity [62]. Litera-
ture reports a number of microRNAs, mainly miR-21,
miR-155, miR-146a, miR-223 to be important regulators
of the protein coding genes involved in the above men-
tioned pathways [60], [61], [63]. Studies on microRNA ex-
pression in bacterial infections of various sources similarly
point towards the same microRNAs [20], [17], [64], [65]
as the key players in the host response. We found 17
microRNAs up regulated in necrotic versus visually un-
affected sample, while the protein coding study on the
same biological material found that the highest number of
deregulated genes was in the necrotic area [23]. The
microRNAs showing remarkably high expression level in
our study namely miR-21 is a powerful anti-inflammatory
regulator, which by direct targeting of a PDCD4 gene inhi-
bits the pro-inflammatory regulator NF-kB. Moreover, the
levels of anti-inflammatory cytokine IL-10 are increased
upon miR-21 up-regulation [65]. However, our study
detected an extremely high expression of miR-21 in all
the samples, regardless the infection status. Similar
results of high expression of miR-21 have been found
in viral infection of porcine dendritic cells [66].
Two targets of miR-21: Interleukin I Beta (IL1β)
and tumor necrosis factor, alpha-induced protein 3
(TNFAIP3), which is rapidly induced by the TNF were
assayed by RT-qPCR on mRNA in another APP infection
study in pigs [23]. In the study of Mortensen and colla-
borators IL1β was up-regulated in infected samples and
TNFAIP3 was repressed. Ideally, we would expect an up-
regulation of microRNA while mRNA is attenuated and
vice versa. However, the lack of such correlation is not
necessarily contradictive to the nature of microRNA
mediated regulation. A single mRNA can be fine-tuned
by multiple microRNAs and this regulation is a very
complex, multi-factorial and time dependent network
and possibly samples taken at different time points of in-
fection would result in slightly different profiles.
The following key player in control of immunity and
inflammation, miR-155, showed rather contradicting
results to those existing in the literature [18]; [67]; [68].
In our RT-qPCR study, miR-155 was significantly down-
regulated under pathogen triggered inflammation and so
was mRNA coding for the miR-155 target IFN-γ in the
same animals [23].
The 5b APP serotype used in the present study is
highly virulent. It has been show that the lethality of
pleuropneumonia in pigs is not necessarily caused by
ventilator failure [69] but by a septic shock-like condi-
tion, which develops when, immunological and inflam-
matory responses are unbalanced and uncontrolled
release of cytokines occurs [8]. Such dramatic dis-
turbance in regulation of immune response could be the
explanation for the surprisingly reversed miR-155 ex-
pression profile.
Another microRNA candidate namely miR-223 was
investigated in the present study. We indeed detected a
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remarkable, gradually increasing expression of miR-223
with infection progression, in infected samples in
comparison to the control. Moreover, Matsushima and
co-workers (2011) found miR-223 to be the only up-
regulated microRNA in Helicobacter pylori-infected
gastric mucosa. TLR4 and TLR3 pathways are pos-
sibly targeted by miR-223 [64].
Nearly all up-regulated microRNAs in lung tissue from
infected pigs target IL-6R and/or IL6ST, in addition miR-
144 and miR-146a 5p targets mRNA coding for IL-6. IL-6
was found to be highly up-regulated in the same animals
[24] 14–18 h after experimental infection. We might
speculate that expression of this pro-inflammatory cyto-
kine as well as its receptor will be tightly regulated in
order to avoid host mediated tissue damage. Unpub-
lished time-course studies of mRNA from lung tissue re-
veal IL-6 first to be highly up-regulated and then to be
significant down-regulated somewhere between 12 and
24 h after infection with APP (Skovgaard, personal com-
munication) MicroRNA miR-148a and miR-126 are also
mentioned in the inflammation related literature with
miR-148a having implication in function of primary
bronchial epithelial cells [70] and miR-126 in chronic
asthma where initial increase in expression of this
microRNA was found [71]. The miR-148a similarly to
miR-146a-5p was found to target mRNA encoding
IRAK1. Our most confident prediction for miR-148a is a
SMAD2 gene involved in regulation of cell growth and
proliferation - two processes which are rather silenced dur-
ing stressful bacterial infection. This corresponds to great
up-regulation of miR-148a in infected tissue. Interestingly,
Interleukin 21 receptor (IL21R) is regulated by miR-126.
Interleukin 21 is yet another immunoregulatory cytokine
though to be involved in transition from innate to adaptive
immunity. The remaining microRNA candidates namely:
miR-15a, -142-5p, -144, -451 and −664 were not previously
described as important in response to infectious pathogen
lung infection. Nevertheless, we provide a very distinct and
significant expression profiles supported by multiple target
predictions for those microRNAs, which suggest that they
might be a new coming group of microRNAs involved in
inflammation regulatory networks.
Conclusion
This is to our knowledge the first study to survey the
host microRNA expression profiles in Actinobacillus
pleuropneumoniae lung infection in pig. We provide
insight into involvement of a collection of microRNAs
in regulation of immune and inflammatory response
during porcine lung infection. A number of those micro-
RNAs have not previously been described as regulators
of immune system, which might point towards their pos-
sible organ specific, infection time specific or species
specific role. Furthermore, the atlas of annotated and
novel porcine microRNAs expressed in different areas
of infected lungs is described. The complexity of the
microRNA-target regulation suggests that the network
should be rather viewed as a multi-factorial structure
that fine-tunes plasticity of inflammation rather than a
set of isolated regulatory events. We believe that better
understanding of the possible role of microRNAs modu-
lating PRR signaling in response to pathogens, by target-
ing different components of these complex pathways
firstly contributes to better understanding of the com-
plex regulation and secondly may contribute to drug
improvements in the future. This study builds a back-
ground for miRNA-target interaction based-research in
APP infection in pig. Furthermore, the findings of the
present study combined with translational studies can
contribute to elucidate mechanisms responsible for sus-
ceptibility to and pathophysiology of lung infection in
other organisms including humans.
Methods
Experimental infection
Ten, 8–10 weeks old castrates, Danish crosses between
Landrace/Yorkshire/Duroc, free from Actinobacillus
pleuropnemonia, were inoculated intranasally with A.
pleuropneumoniae serotype 5b, isolate L20 as described
previously in [72]. Re-isolation of the inoculum strain of
A. pleuropneumoniae was performed from all inoculated
animals. Severity of lung lesions characteristic of pleuro-
pneumonia was rated by a highly skilled pathologist.
Animals were sacrificed 14–18 h after the inoculation.
All animal procedures were approved by the Danish
Animal Experiments Inspectorate. Lung, trachea and
nose tissues were sampled and immediately snap frozen
in liquid nitrogen and stored in −80 °C until used. Lung
samples were taken from three different sites: necrotic
area, demarcation zone, and visually unaffected area. For
detailed description of the infection study see [23]. For
present study, samples of necrotic lung of eight animals
(severe lesions and necrosis present in the lung tissue),
of demarcation zone in lung of eight animal (sample
taken at the border area between visually unaffected and
pulmonary lesions) and samples of visually unaffected
lung from ten animals (healthy-looking unaffected lung
tissue) (Figure 5), trachea and nose (ten animals each)
were taken. Furthermore, additional samples were ob-
tained from control porcine lung tissue (control samples
independent of the infection study), porcine lung tissue
from fetus gestation day 50 (F50) and porcine lung tissue
from fetus gestation day 100 (F100). All three of the
above groups were free from APP infection.
RNA extraction
Total RNA was extracted from each necrotic lung, visu-
ally unaffected lung, demarcation zone lung, trachea,
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nose, F50, F100 and control porcine sample, using Tri
ReagentW (Molecular Research Center, Inc., USA) follow-
ing the manufacturers recommendations. App. 300 mg
of each tissue was used for the isolation procedure. RNA
quantity was determined on a Nanodrop 1000 (Peqlab
Biotechnologie, Germany). Additionally, the integrity of
the total RNA samples was measured by total RNA Assay
and Experion RNA StdSens Analysis Kit using 2100 Bioa-
nalyzer (Agilent Technologies, Santa Clara, CA, USA),
and Experion (Bio-Rad Laboratories, Inc., Hercules, CA,
USA) respectively. The RNA concentrations assessed by
Nanodrop as well as the integrity values of RIN and RQI
are provided in the Additional file 12.
Small RNA library and Solexa sequencing
Total RNA fractions from eight necrotic and ten visually
unaffected samples were pooled, respectively and used
for the small RNA library construction following stand-
ard Illumina protocols version 1.5. Briefly, RNAs were
ligated to a 5’ and a 3’ adapter sequentially, reverse tran-
scribed into cDNA, PCR amplified with adapter specific
primers, and finally the small RNAs were purified on 3%
MetaPhorW Agarose gel (Cambrex Bio Science Rockland,
USA) to generate suitable length of tags for small RNA
sequencing performed on Illumina Genome Analyzer IIx
(Illumina GAIIx).
Computational analysis of high throughput sequencing
data
Alignment and clustering of reads
The reads were filtered for chastity by the Illumina pipeline,
after which they were aligned to version 9.0 of the pig gen-
ome using Novoalign version 2.05.25. The reads were
stripped of adapter allowing for up to two mismatches, and
minimum insert lengths of 18 nucleotides were required
prior to alignment. Novoalign's microRNA scoring scheme
was employed. All alignments, no more than five points
away from the best alignment are reported by Novoalign.
Novoalign filters for quality, strips adapter sequence, and
filters out homo-polymer reads prior to aligning to the gen-
ome. Only the aligned reads mapping uniquely were used
for read clustering. The reads in each library were clustered
allowing for a gap of up to 15 uncovered nucleotides before
breaking a cluster. Clusters were then merged between the
two libraries to get one consistent set of clusters.
Annotation
The read clusters were annotated using a number of
methods: The Ensembl protein annotation for build 9.0
of porcine genome; the high confidence BLAST (95% id,
95% length) [34] against Rfam 9.1 [36] the snoRNA data-
base version 3 [73], the tRNA database [74], the miRBase
version 14 (miRBase version 16 for porcine miRNAs)
[75]; the RNAmmer version 1.2 for ribosomal RNAs [76];
the tRNAscan-SE for tRNAs [77]; and finally Infernal 1.0
[35]. Rfam 9.1 against all Rfam models (the results where
filtered with the model specific gathering score plus an
infernal e-value cutoff of 1e-3). BLAST conflicts were
resolved by taking the ncRNA that scored best e-values.
When a cluster was annotated by more than one method,
the conflicts were checked manually. Annotation is strand
specific and is further cleaned according to the number
of reads covered on a given strand. Annotations, which
accounted for less than 40% of the reads on the same
strand in a cluster were dropped. If an annotation
spanned over more than one cluster, the clusters were
merged prior to further analysis.
Cross species conservation and novel ncRNAs
A UCSC (The University of California, Santa Cruz) gen-
ome browser style multiple alignment based on pig and
17 other vertebrates was performed using lastz [78] and
the UCSC tool chain as part of our in house ncRNA pipe-
line. Pairwise alignments on chunked up genomes were
performed by lastz, followed by chained alignments, and
single best coverage alignments (nets) of the target gen-
ome (pig) with the UCSC tool chain. The single best
coverage alignments were cleaned up by synteny when
the query genome assembly was chromosome based and
by reciprocal best alignments between query and target
when the query genome assembly was scaffold based. Pig
centered, multiple alignments were formed from the
pairwise alignments with the roast program from the
tba/multiz [79] package using a minimal alignment block
size of 40. Structured novel ncRNAs were predicted from
the multiple alignments by RNAz version 2 pre-release
based on structure conservation in between species [80].
Search for novel miRNAs
Novel miRNAs were explored using the miRDeep2 pipe-
line [39]. The reads were aligned using Bowtie and reads
matching up to five different places in the genome were
used for further analysis. A maximum of 1 mismatch
was allowed. The aligned reads were checked for known
miRNAs using the mature miRNAs from Sus scrofa,
Homo sapiens, Equus caballus, Bos Taurus, respectively
and the full hairpins from Sus scrofa, all from miRBase
version 17. The miRDeep2 pipeline confirms the folding
ability of the miRNAs with RNAfold, and the miRNA
probability is checked with Randfold. We further
restricted the set of novel miRNAs by confirming them
with the unique mappings of the Novoalign alignment
and by requiring either structure conservation by RNAz
or by confirming both mature and star sequence reads.
Normalization
In this experiment the libraries and raw reads could not
be compared directly due to large variation in the
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fractions of degraded RNAs. We therefore chose to treat
the miRNAs from each sample separately, which leads
to summed miRNA raw reads of 791541 and 4672073,
respectively for the 180 miRNAs detected in the sam-
ples. When the samples as here are very diverse it is fur-
ther recommended to calculate normalization factor by
the threaded means of M-values (TMM) method [81].
We found normalization factors of 0.9359472 and
1.0684363, respectively. The p-values of the relative
expressions in the two tissues were calculated by the
exact-test build into the edgeR package [82]. An estima-
tion of sample dispersion is needed to use this test, and
in the absence of replicated samples we follow the
authors’ recommendation of using a dispersion factor
of 0.1 for genetically identical samples.
Target predictions
We used miRNA/protein target data for human from
the following sources TargetScan [43-46], PicTar [47],
[48], miRanda [49], [50] and microT [51]. TargetScan
version 5.0 vertebrate dataset with conserved target sites
was used. For PicTar we used the four way results for
hg17 downloadable from the UCSC browser; the august
2010 dataset with “good scores” and conserved target
sites were used for miRanda. For microT, the version 4
dataset with a score cutoff of 0.3 was applied. The pro-
tein annotations were transferred to Ensembl gene iden-
tifiers and from there to gene symbols using biomart
[83]. Some protein annotations did not have matching
identifiers or gene symbols therefore were discarded.
The predictions for the novel miRNAs were performed
with TargetScan, which allows accessible off-line use.
Human was chosen as the target organism and limit to
target sites widely conserved in mammals was applied.
cDNA synthesis for RT-qPCR
Individual samples from all animals mentioned in the
experimental infection section above were subjected to
RT-qPCR study. The integrity of the total RNA ranged
from 6.2-8.7. For more details see Additional file 12.
100 ng of total RNA was used for reverse transcription.
A cDNA panel of duplicates for each biological sample
was constructed including: 16 necrotic lung, 14 demar-
cation zone lung, 16 unaffected lung, 8 adult, 8 F100,
8 F50, 8 trachea and 8 nose samples (43 biological sam-
ples in duplicates making 86 cDNA samples all to-
gether). cDNA synthesis was performed as described in
details in [91]. Briefly, 100 ng of RNA in a final volume
of 10 μl including 1 μl of 10x poly(A) polymerase buffer,
0.1 mM of ATP, 1 μM of RT-primer (5'-CAGGTC-
CAGTTTTTTTTTTTTTTTVN, where V is A, C and G
and N is A, C, G and T). The primer was purchased
from TAG Copenhagen (Denmark), 0.1 mM of each
deoxynucleotide (dATP, dCTP, dGTP and dTTP), 100
units of MuLV reverse transcriptase (New England
Biolabs, USA) and 1 unit of poly(A) polymerase (New
England Biolabs, USA) were incubated at 42°C for
1 hour followed by enzyme inactivation at 95°C for
5 minutes. The cDNA was diluted 8 times before used
for RT-qPCR reaction.
This miR-specific qPCR method as previously de-
scribed in [84], [85] depends on polyA-tailing at the
3'-end of the miRNA followed by sequence-specific
PCR. However, this 3'-end is not available if the miR
is located at the 5'-end of the pre-miRNA (5'-miRNA
or miRNA-5p). Therefore, miR-specific qPCR only de-
tects the mature miRNA and not the pre-miRNA for
5'-miRNAs/miRNA-5p (Busk, 2010). In contrast, when
the miRNA is located at the 3'-end of the pre-miRNA
(3'-miRNA or miRNA-3p) the miRNA and the pre-miRNA
have identical 3'-ends. Therefore, miR-specific qPCR
will detect both the miRNA and the pre-microRNA in
the case of 3'-miRNAs/miRNA-3p [85].
Of the miRNAs investigated in the present study,
miR15a, miR21, miR126, miR142-5p, miR144-5p,
miR146a-5p, miR148a, miR152, miR155, miR192, miR-
223, miR-45 and miR-d5 are 5'-miRNAs hence only the
mature miRNAs of these targets were detected. For
miR-143-3p, which is a 3'-miRNA both the mature
miRNA and the pre-miRNA were detected.
Quantitative RT-PCR of microRNAs
Fourteen candidate genes (13 microRNAs and 1 snoRNA)
and two reference genes (miR-152 and MiR-191) were
assayed by RT-qPCR. Primer sequences for each as-
sayed ncRNA gene (including reference genes) are listed
in the Additional file 13. Semi Quantitative PCR of 86
samples was performed on a MX3000P machine (Strata-
gene, USA) in 10 μl total volume with 1 μl of diluted
cDNA, 5 μl of 2x QuantiFast SYBR Green PCR master
mix (Qiagen, Germany), 250nM of each primer (Add-
itional file 13). Standard curves with 5-fold dilutions
(made with a pool of equal amounts of cDNA from the
88 samples) were made for all assays to calculate the RT-
qPCR efficiency. Cycling conditions were 95°C for 5 min
followed by 40 cycles of 95°C for 10 sec and 60°C 30 sec.
A melting curve analysis (60°C to 99°C) was performed
in the last cycle, to evaluate specificity of the
amplification.
RT-qPCR data analysis
PCR efficiency was calculated from the log-linear por-
tion of the standard curves [86]. GeneEx (MultiD) soft-
ware was used to perform the analysis. Briefly, Cq values
for each assayed microRNA/snoRNA were imported to
GeneEx software. Data were corrected for efficiencies
(ranging from 81 to 98%) for each primer assay individu-
ally, followed by the normalization of the expression of
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target genes to the expression of reference genes namely:
miR-152 and miR-191. Technical cDNA replicates were
averaged and relative quantities were calculated com-
pared to the control group (lung samples from unin-
fected pigs). Prior to statistical analysis, the data was
LOG2 transformed to assure normal distribution. The
one factor Analysis of Variance (ANOVA) testing for sig-
nificant differences between the means of the analyzed
groups was performed. The confidence level was set at
95%. Tukey-Kramer's test was chosen as the post test for
the all pairwise comparisons. The summary of the statis-
tical analysis for all the sample groups is included in
Additional files 8 and 14 The results are presented as a
table for each gene, with sums of squares (SS), degrees
of freedom (df ), mean sums of squares (MS), F-statistics
(F), and p-value (for detailed comparisons see Additional
files 3 and 4). Significance threshold was set at p-value >
0.05. RT-qPCR experiment as well as the data analysis
is MIQE guidelines compliant [86].
Additional files
Additional file 1: Profiles of read clusters for novel miRNAs from
miR-d1 to miR-d6.
Additional file 2: Profiles of read clusters for novel miRNAs from
miR-d7 to miR-d12.
Additional file 3: The known miRNAs of the miRDeep2 pipeline
missed by the unique mappings from Novoalign. 24 of these miRNAs
are found twice in the genome, indicating assembly errors. Raw reads are
un-normalized and according to the Bowtie alignment produced by
miRDeep.
Additional file 4: Expression of the all the detected miRNAs.
Columns 6 and 7 contain the raw reads in the two samples. Columns 8
and 9 are the read counts normalized by the TMM method. Column 10 is
log2 of the fold change based on the normalized read counts. Column
11 is the p-values for the relative expression based on the exact test from
the edgeR package using a dispersion-factor of 0.1. (see Methods for
details).
Additional file 5: Top 20 snoRNAs in the necrotic tissue. Infernal
e-values are given for the annotation.
Additional file 6: Top 20 snoRNAs in the unaffected tissue. Infernal
e-values are given for the annotation.
Additional file 7: Bar diagram showing RT-qPCR results of
expression of 13 selected unique miRNAs and one snoRNA. miR-d5
represents a novel unannotated microRNA. All eight sample groups
included.
Additional file 8: Statistical analysis of qPCR results: One way
ANOVA performed on four groups: control, visually unaffected,
demarcation zone, necrotic.
Additional file 9: Targets predicted for 12 select miRNAs and 91
select proteins. Only targets predicted by two or more of the four
target prediction methods (see Methods for details).
Additional file 10: Conservation of miRNAs found in this article. In
column 2–5 the conservation is based on full genomic pairwise
alignments of pig and 17 other mammalian genomes (bosTau4, turTru1,
equCab2, felCat3, canFam2, eriEur1, hg19, tarSyr1, mm9, rn4, oryCun2,
loxAfr3, echTel1, dasNov2, choHof1, monDom5, ornAna1). The miRNA pig
coordinates are required to transfer to the target organism, and the
coordinates in the target organism is required to transfer back to the
same position in pig to avoid paralogous alignments. The pig sequence
is then aligned to the target sequence and a minimum align length of
50 and an identity of at least 50% is required for the miRNA to be
counted in the third column. In columns 2 and 3 the pairwise identity
between the pig sequence and cow or human is given, and in column 4
the number of organisms where the miRNA is found is given and finally
in column 5 the mean pairwise identity is given. Columns 6–9 are
analogous to column 2–5, except the identification of the miRNAs in the
target organism are now identified by a BLAST of mirBase version 18
against the target genome. The pig and target sequence are then
aligned in the same way as before.
Additional file 11: Targets predicted with TargetScan for mir-d5
and mir-d11 for which the set of conserved target sites gave few
results. The targets are predicted for 3’ UTRs from cow since the pig
ones are not in the dataset for TargetScan (see Methods for details).
Additional file 12: Table listing values describing the quantity and
integrity of all RNA samples.
Additional file 13: Table listing RT-qPCR primer sequences for each
assayed miRNA and snoRNA. * indicates reference genes.
Additional file 14: Statistical analysis of qPCR results. One way
ANOVA performed on eight groups: trachea, nose, F50, F100, control,
visually unaffected, demarcation zone, necrotic.
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